PRELUDE CAPITAL MANAGEMENT, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 209 filers reported holding PTC THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$619,323
+54.2%
15,228
+83.7%
0.04%
+66.7%
Q1 2023$401,519
+73.8%
8,289
+79.8%
0.02%
+200.0%
Q3 2022$231,000
+278.7%
4,609
+254.5%
0.01%
+166.7%
Q3 2020$61,000
-86.4%
1,300
-85.3%
0.00%
-88.0%
Q2 2020$448,000
+153.1%
8,831
+122.2%
0.02%
+108.3%
Q1 2020$177,000
-87.8%
3,975
-86.8%
0.01%
-78.2%
Q4 2019$1,449,000
+10250.0%
30,167
+7257.8%
0.06%
+5400.0%
Q3 2019$14,000
-99.3%
410
-99.1%
0.00%
-99.0%
Q2 2019$2,006,000
+158.5%
44,573
+116.3%
0.10%
+125.0%
Q1 2019$776,000
-78.8%
20,605
-73.6%
0.04%
-79.3%
Q3 2018$3,669,000
+4.6%
78,071
-24.9%
0.21%
-4.1%
Q2 2018$3,507,000
-23.3%
103,959
-38.5%
0.22%
-33.1%
Q1 2018$4,572,000
-5.0%
168,963
-41.4%
0.33%
-14.0%
Q4 2017$4,812,000
-26.4%
288,469
-11.8%
0.39%
-34.5%
Q3 2017$6,540,000
+26.4%
326,879
+15.8%
0.59%
+20.2%
Q2 2017$5,173,000
+46.8%
282,224
-21.2%
0.49%
+45.4%
Q1 2017$3,524,000
+60.3%
358,095
+77.8%
0.34%
+26.7%
Q4 2016$2,198,000
-27.4%
201,424
-6.7%
0.27%
-16.1%
Q3 2016$3,026,000
+4780.6%
215,971
+2354.2%
0.32%
+3422.2%
Q2 2016$62,000
-59.5%
8,800
+53.4%
0.01%
-59.1%
Q3 2015$153,000
+350.0%
5,737
+719.6%
0.02%
+340.0%
Q2 2015$34,0007000.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders